Submission Details
| 510(k) Number | K024017 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 04, 2002 |
| Decision Date | January 30, 2003 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K024017 is an FDA 510(k) clearance for the BAYER ADVIA CENTAUR HER-2/NEU ASSAY, a System, Test, Her-2/neu, Monitoring (Class II — Special Controls, product code NCW), submitted by Bayer Corp. (Tarrytown, US). The FDA issued a Cleared decision on January 30, 2003, 57 days after receiving the submission on December 4, 2002. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.
| 510(k) Number | K024017 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 04, 2002 |
| Decision Date | January 30, 2003 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | NCW — System, Test, Her-2/neu, Monitoring |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.6010 |